Providence Capital Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.04M Buy
32,977
+895
+3% +$137K 0.82% 52
2025
Q4
$4.42M Buy
32,082
+1,108
+4% +$145K 0.74% 53
2025
Q3
$3.97M Buy
30,974
+845
+3% +$103K 0.69% 55
2025
Q2
$3.65M Buy
30,129
+840
+3% +$94.7K 0.67% 58
2025
Q1
$3.27M Buy
29,289
+369
+1% +$39.3K 0.68% 60
2024
Q4
$2.81M Buy
28,920
+7
+0% +$746 0.57% 69
2024
Q3
$3.33M Sell
28,913
-6,620
-19% -$751K 0.66% 64
2024
Q2
$3.78M Buy
35,533
+416
+1% +$41.8K 0.82% 50
2024
Q1
$3.4M Buy
35,117
+813
+2% +$83.4K 0.74% 57
2023
Q4
$3.46M Sell
34,304
-1,103
-3% -$106K 0.83% 52
2023
Q3
$3.61M Buy
35,407
+193
+0.5% +$19.6K 0.94% 51
2023
Q2
$3.55M Buy
35,214
+518
+1% +$51.8K 0.9% 52
2023
Q1
$3.19M Buy
34,696
+588
+2% +$51.4K 0.84% 53
2022
Q4
$3.09M Sell
34,108
-2
-0% -$168 0.84% 55
2022
Q3
$2.59M Buy
34,110
+698
+2% +$57.9K 0.78% 59
2022
Q2
$2.82M Buy
33,412
+10,595
+46% +$930K 0.82% 57
2022
Q1
$1.99M Buy
22,817
+1,835
+9% +$159K 0.49% 82
2021
Q4
$1.83M Buy
20,982
+833
+4% +$69.2K 0.51% 74
2021
Q3
$1.65M Buy
20,149
+1,857
+10% +$167K 0.51% 74
2021
Q2
$1.67M Buy
18,292
+1,095
+6% +$97.5K 0.55% 68
2021
Q1
$1.47M Buy
17,197
+372
+2% +$33.4K 0.54% 69
2020
Q4
$1.59M Buy
16,825
+1,715
+11% +$150K 0.65% 57
2020
Q3
$1.31M Buy
15,110
+488
+3% +$42.3K 0.69% 54
2020
Q2
$1.28M Sell
14,622
-122
-0.8% -$10.5K 0.72% 53
2020
Q1
$1.22M Buy
+14,744
New +$1.32M 0.73% 56
2018
Q1
Sell
-50
Closed -$4K 286
2017
Q4
$4K Buy
+50
New +$3.77K ﹤0.01% 279

Other funds holding NVS